Astrazeneca Pharma India Ltd
22 February 2025 13:33|BSE : 506820|NSE : ASTRAZEN|ISIN : INE203A01020
22 February 2025 13:33|BSE : 506820
NSE : ASTRAZEN|ISIN : INE203A01020
Astrazeneca Pharma India is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. It has a workforce of over 1400 employees across the country that is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory.
Astrazeneca Pharma India is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. It has a workforce of over 1400 employees across the country that is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory.
FAQs
How to buy Astrazeneca Pharma India Ltd shares?
What is the current Market Cap of Astrazeneca Pharma India Ltd?
What is the current PE and PB ratio of Astrazeneca Pharma India Ltd?
Open Free Demat Account
Kickstart your investment journey